Delivery Order SPE2DB20D3304-SPE2DB24FW6Q2

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,418.90 to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and is valid through December 31, 2025. The IDC allows DLA to efficiently procure...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $3,940.92, runs through April 19, 2024 and was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This IDC...
The U.S. Defense Logistics Agency (DLA) awarded a $1,813.11 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4565096384 - TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of July 10, 2024 and is a firm fixed price arrangement. Amerisourcebergen is a major pharmaceutical distributor that holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The firm-fixed-price contract has a ceiling value of $3,518.16 and a completion date of June 13, 2024. This contract award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The Firm Fixed Price contract, valued at $2,570.12, has a completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 0.75 mg/0.5 ml TRULICITY pens (0.5 ml). The $5,909.85 firm fixed price contract has a completion date of May 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical products and medical supplies to support the Department of Defense. The company also...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The fixed-price contract, valued at $6,503.87, has a completion date of June 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 and running through December 31, 2025. Under this IDC, Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The $1,741.68 firm-fixed-price contract has a completion date of September 9, 2024 and is not a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $2,760.96 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 0.75 mg/0.5 ml pens. The $7,965.65 contract has an ultimate completion date of April 2, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW6Q2
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The award, valued at $2,938.44, is a Firm Fixed Price contract with a completion date of July 2, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 9/30/24, 4:22 PM